<code id='4040B9A17F'></code><style id='4040B9A17F'></style>
    • <acronym id='4040B9A17F'></acronym>
      <center id='4040B9A17F'><center id='4040B9A17F'><tfoot id='4040B9A17F'></tfoot></center><abbr id='4040B9A17F'><dir id='4040B9A17F'><tfoot id='4040B9A17F'></tfoot><noframes id='4040B9A17F'>

    • <optgroup id='4040B9A17F'><strike id='4040B9A17F'><sup id='4040B9A17F'></sup></strike><code id='4040B9A17F'></code></optgroup>
        1. <b id='4040B9A17F'><label id='4040B9A17F'><select id='4040B9A17F'><dt id='4040B9A17F'><span id='4040B9A17F'></span></dt></select></label></b><u id='4040B9A17F'></u>
          <i id='4040B9A17F'><strike id='4040B9A17F'><tt id='4040B9A17F'><pre id='4040B9A17F'></pre></tt></strike></i>

          entertainment

          entertainment

          author:hotspot    Page View:65196
          Bruce Broussard. -- health business coverage from STAT
          Humana CEO Bruce Broussard Jason DeCrow/AP

          Bruce Broussard, CEO of health insurance giant Humana, will step down next year after leading the company for more than a decade.

          Humana named Jim Rechtin — who is the CEO of Envision Healthcare, the controversial physician staffing firm that is working its way through bankruptcy — as Broussard’s replacement. Rechtin will serve as president and chief operating officer starting Jan. 8 and then take over as CEO in the “latter half of 2024,” the company said in a news release.

          advertisement

          Humana’s stock fell by more than 2% on the news Wednesday morning.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          A public scorecard can help hold safety
          A public scorecard can help hold safety

          AdobeCaliforniaregulatorsannouncedlastmonthplanstoevaluatewhethersafety-netpatientsfaceimproperlylon

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          AI models in health care face new federal disclosure requirements

          AdobeFederalhealthtechnologyregulatorsonWednesdayfinalizednewrulestoforcesoftwarevendorstodiscloseho